The ESG Weekly: Pipelines are OVER; and are drug prices too high?
A ruling by a US judge has put the entire oil and gas pipeline industry at risk in the US, and a lot of it is because companies have terrible community relations. And then, we discuss the price tag on Remdesivir, the first drug shown to be effective against the coronavirus ‐ and how drug prices affect company incentives.
